Frank SlackDirector, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School Frank Slack received his B.Sc. from the University of Cape Town in South Africa, before completing his Ph.D. in molecular biology at Tufts University School of Medicine. He started work on microRNAs as a postdoctoral fellow in Gary Ruvkun’s laboratory at Harvard Medical School, where he co-discovered the second known microRNA, let-7. He is currently Director, Institute of RNA Medicine at the Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School in Boston, MA. Professor Slack has pioneered various aspects of the microRNA field and continues to make important contributions to this aspect of post-transcriptional control of gene regulation in stem cell development, cancer and aging. For example Professor Slack and colleagues were co-discoverers of the second known microRNA, let-7 (Reinhart et al Nature, 2000), and the co-discoverers of the first known human microRNA (Pasquinelli et al. Nature, 2000). |
Jingde ZhuPrinciple Investigator, Shanghai Jiaotong University Jingde Zhu, Ph.D (1985) in molecular pathology from Beatson Institute for Cancer Research, Glasgow, UK and worked as a senior scientist or PI in Shanghai Institute of Cell Biology, three academic institutions and one biotech firm in UK between 1985-2001. His research focuses at the epigenetic (-omic) perspectives (DNA methylation in particular) of biological behavor of cancer and its detetion. He is the inventor for both approved and filed patents (six) in China and in US. He is actively promoting the regional and global epigenome efforts. |
